Cytotoxicity of octal-bromide zinc phthalocyanine after photodynamic therapy with different light sources

Photomedicine and Laser Surgery

Volumn 26, Issue 5, 2008, Pages 455-459

  Machado, Aline Helena Araujo ^a   Soares, Cristina Pacheco ^a   Junior, Milton Beltrame ^a   Pacheco, Marcos Tadeu Tavares ^a   Da Silva, Newton Soares ^a  

^a INSTITUTO DE PESQUISA E DESENVOLVIMENTO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL CULTURE; CELL CULTURE; CELLS; CONCENTRATION (PROCESS); CYTOLOGY; DIODES; ELECTRIC CONDUCTIVITY; HETEROJUNCTIONS; IRRADIATION; LASERS; LIGHT; LIGHT EMITTING DIODES; LIGHT SOURCES; LIGHTING; OPTICAL MATERIALS; PHOTODYNAMIC THERAPY; PHOTOSENSITIZERS; PLASMONS; RADIATION; SEMICONDUCTOR DIODES; SEMICONDUCTOR LASERS; SEMICONDUCTOR MATERIALS; ZINC; ZINC COMPOUNDS;

CELL VIABILITIES; COMPARATIVE EVALUATIONS; ENERGY DENSITIES; HUMAN DISEASES; IN VITRO; IRRADIATION PARAMETERS; PHOTODYNAMIC EFFICACIES; TRYPAN BLUE DYES; ZINC PHTHALOCYANINES;

ELECTROMAGNETIC WAVES;

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; OCTAL BROMIDE ZINC PHTHALOCYANINE; PHOTOSENSITIZING AGENT; TRYPAN BLUE; UNCLASSIFIED DRUG;

ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIODE LASER; DRUG CYTOTOXICITY; DRUG EFFICACY; ENERGY TRANSFER; HEP 2 CELL; HUMAN; HUMAN CELL; PHOTODYNAMIC THERAPY; SEMICONDUCTOR;

CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL SURVIVAL; EPITHELIAL CELLS; HUMANS; OPTICAL DEVICES; ORGANOMETALLIC COMPOUNDS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

EID: 54049151176     PISSN: 15495418     EISSN: None     Source Type: Journal    
DOI: 10.1089/pho.2007.2117     Document Type: Article

References (19)

1. Pervaiz, S., and Olivo, M. (2006). Frontiers in research review: Cutting-edge molecular approaches to the therapeutic art and science of photodynamic therapy. Clin. Exp. Pharmacol. Physiol. 33, 551-556.
2. You, Y., Gibson, S.L., and Detty, M.R. (2006). Phototoxicity of a core-modified porphyrin and induction of apoptosis. J. Photochem. Photobiol. B. Biol. 85, 155-162.
3. Triesscheijn, M., Baas, P., Schellensa, J.H.M., and Stewarta, F.A. (2006). Photodynamic therapy in oncology. Oncologist. 11, 1034-1044.
4. Qiang, Y.G., Zhang, X.P., Li, J., and Huang, Z. (2006). Medical progress Photodynamic therapy for malignant and non-malignant diseases: clinical investigation and application. Chin. Med. J. 119, 845-857.
5. Kolarová, H., Mosinger, J., Lenobel, R., Kejlová, K., Jírová, D., and Strnad, M. (2003). In vitro toxicity testing of supramolecular sensitizers for photodynamic therapy. Toxicol. In Vitro. 17, 775-778.
6. Ochsner, M. (1997). Photophysical and photobiological processes in photodynamic therapy of tumours. J. Photochem. Photobiol. B. Biol. 39, 1-18.
7. Spesia, M.B., Lazzeri, D., Pascual, L., Rovera, M., and Durantini, E.N. (2005). Photoinactivation of Escherichia coli using porphyrin derivatives with different numbers of cationic charges. FEMS Immunol. Med. Microbiol. 44, 289-295.
8. Alvarez, M.G., Prucca, C., Milanesio, M.E., Durantini, E.N., and Rivarola, V. (2006). Photodynamic activity of a new sensitizer derived from porphyrin-C60 dyad and its biological consequences in a human carcinoma cell line. Int. J. Biochem. Cell. Biol. 38, 2092-2101.
9. Mori, M., Campolmi, P., Mavilia, L., Rossi, R., Cappugi, P., and Pimpinelli, N. (2006). Topical photodynamic therapy for primary cutaneous B-cell lymphoma: A pilot study. J. Am. Acad. Dermatol. 54, 524-526.
10. Alexiades-Armenakas, M. (2006). Laser-mediated photodynamic therapy. Clin. Dermatol. 24, 16-25.
11. Oberholzer, T.G., Preez, I.C.D., and Kidd, M. (2005). Effect of LED curing on the microleakage, shear bond strength and surface hardness of a resin-based composite restoration. Biomaterials. 26, 3981-3986.
12. Collier, A.C., and Pritsos, C.A. (2003). The mitochondrial uncoupler dicumarol disrupts the MTT assay. Biochem. Pharmacol. 66, 281-287.
13. Trevisi, L., Pighin, I., Bazzan, S., and Luciani, S. (2006). Inhibition of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) endocytosis by ouabain in human endothelial cells. FEBS Lett. 580, 2769-2773.
14. Hamid, R., Rotshteyn, Y., Rabadi, L., Parikh, R., and Bullock, P. (2004). Comparison of alamar blue and MTT assays for high through-put screening. Toxicol. In Vitro. 18, 703-710.
15. Lobner, D. (2000). Comparison of the LDH and MTT assays for quantifying cell death: validity for neuronal apoptosis? J. Neurosci. Met. 96, 147-152.
16. Vellonen, K.S., Honkakoski, P., and Urtti, A. (2004). Substrates and inhibitors of efflux proteins interfere with the MTT assay in cells and may lead to underestimation of drug toxicity. Eur. J. Pharm. Sci. 23, 181-188.
17. Kelley, E.E., Buettner, G.R., and Burns, C.P. (1997). Production of lipid-derived free radicals in L1210 murine leukemia cells. Is an early oxidative event in the photodynamic action of photofrin? Photochem. Photobiol. 65, 576-580.
18. Machado, A.H.A., Braga, F.M.P., Pacheco-Soares, C., Pelisson, M.M.M., Beltrame-Junior, M., and Da-Silva, N.S. (2007). Photodynamic therapy with a new photosensitizing agent. Photomed. Laser Surg. 25, 220-228.
19. Crescenzi, E., Varriale, L., Iovino, M., Chiaviello, A., Veneziani, B.M., and Palumbo, G. (2004). Photodynamic therapy with indocyanine green complements and enhances low-dose cisplatin cytotoxicity in MCF-7 breast cancer cells. Mol. Cancer Ther. 3, 537-544.